Generated Narrative: Composition Example-SMP-MAPComposition-01 Language: en-US Profile: SMP Composition Medication Action Plan status: Final type: Pharmacology Plan of care note date: 2025-07-02 author: Practitioner Pharmy Anyperson (official) title: SMP Medication Action Plan for examplePatient Attesters - Mode Party * Professional Practitioner Pharmy Anyperson (official)
SMP Medication Action Plan for examplePatient
Medication Action Plan Care Plan for example Patient
Medication management plan (record artifact)
This section contains the Medication Action Plan Care Plan for example Patient.
Medication Action Plan Care Plan Document for example Patient
This section contains the Medication Action Plan Care Plan Document for example Patient.
Generated Narrative: Patient examplePatient John Doe (official) Male, DoB: 1960-01-01 ( http://hospital.example.com/mrn#12345)
Generated Narrative: Practitioner examplePractitioner Profile: US Core Practitioner Profile identifier: United States National Provider Identifier/4077310264 name: Jane Smith (Official) Qualifications - Code * Doctor of Medicine
Generated Narrative: Practitioner examplePharmacist Profile: US Core Practitioner Profile identifier: United States National Provider Identifier/5219705253 name: Pharmy Anyperson (Official) Qualifications - Code * Doctor of Pharmacy
Generated Narrative: CarePlan example-MAP-Alprazolam-Metoclopramide-01 Profile: Standardized Medication Profile - Medication Action Plan status: Draft intent: Plan category: Medication management plan (record artifact) title: Example Med Action Plan (MAP) - Alprazolam and metoclopramide concurrent therapy as detected issue description: Example Med Action Plan (MAP) - Alprazolam and metoclopramide concurrent therapy as DetectedIssue with risk for falls. subject: Betsy Smith-Johnson created: 2025-07-02 author: Practitioner Pharmy Anyperson (official) supportingInfo: DetectedIssue Duplicate Therapy Alert
Example Med Action Plan (MAP) - Alprazolam and metoclopramide concurrent therapy as detected issue
Example Med Action Plan (MAP) - Alprazolam and metoclopramide concurrent therapy as DetectedIssue with risk for falls.
Generated Narrative: MedicationRequest example-MedicationRequest-alprazolam-01 status: Active intent: Order medication: alprazolam 0.5 MG Oral Tablet subject: John Doe (official) Male, DoB: 1960-01-01 ( http://hospital.example.com/mrn#12345) authoredOn: 2025-07-02 requester: Practitioner Jane Smith (official) DosageInstructions - Text * Take as prescribed
Generated Narrative: MedicationRequest example-MedicationRequest-metoclopramide-01 status: Active intent: Order medication: metoclopramide 10 MG Oral Tablet subject: John Doe (official) Male, DoB: 1960-01-01 ( http://hospital.example.com/mrn#12345) authoredOn: 2025-07-02 requester: Practitioner Jane Smith (official) DosageInstructions - Text * Take as prescribed
Generated Narrative: MedicationStatement example-MedicationStatement-alprazolam-01 basedOn: MedicationRequest: status = active; intent = order; medication[x] = alprazolam 0.5 MG Oral Tablet; authoredOn = 2025-07-02 status: Active medication: alprazolam 0.5 MG Oral Tablet subject: Example Patient dateAsserted: 2025-07-02 13:00:00-0800 informationSource: Practitioner Jane Smith (official)
Generated Narrative: MedicationStatement example-MedicationStatement-metoclopramide-01 basedOn: MedicationRequest: status = active; intent = order; medication[x] = metoclopramide 10 MG Oral Tablet; authoredOn = 2025-07-02 status: Active medication: metoclopramide 10 MG Oral Tablet subject: Example Patient dateAsserted: 2025-07-02 13:00:00-0800 informationSource: Practitioner Jane Smith (official)
Generated Narrative: DetectedIssue example-di01-duplicateTherapy Profile: Standardized Medication Profile - Medication Action Plan Detected Issue status: Preliminary code: Duplicate Therapy Alert severity: High patient: John Doe (official) Male, DoB: 1960-01-01 ( http://hospital.example.com/mrn#12345) identified: 2025-07-02 08:00:00+0000 author: Practitioner Pharmy Anyperson (official) implicated: alprazolam 0.5 MG Oral Tablet metoclopromide 10 MG Oral Tablet detail: Taking these medications contribute a risk of anticholinergic side effects that increase risk of cognitive impairment, dementia and falls. Mitigations - Action Date Author * Discontinue noted medications to prevent cognitive worsening, due to duplicative impact with other anticholinergics. 2025-07-02 08:00:00+0000 Practitioner Pharmy Anyperson (official)
Taking these medications contribute a risk of anticholinergic side effects that increase risk of cognitive impairment, dementia and falls.
Discontinue noted medications to prevent cognitive worsening, due to duplicative impact with other anticholinergics.
Generated Narrative: DocumentReference Example-DocumentReference-PatientSummary20250709093054 status: Current type: Pharmacology Plan of care note subject: John Doe (official) Male, DoB: 1960-01-01 ( http://hospital.example.com/mrn#12345) date: 2025-07-09 09:30:54+0000 content Attachments - ContentType Data Title Creation * application/pdf (base64 data - 441,352 base64 chars) User_SpheregenTest 1 03_Jul_2025_10322264 Default Pharmacy Facility 1.pdf 2025-07-09 09:30:54+0000
User_SpheregenTest 1 03_Jul_2025_10322264 Default Pharmacy Facility 1.pdf